Redesigning clinical trials in the era of precision medicine
4 Jul 2017
Redesigning clinical trials in the era of precision medicine
Genomic-driven clinical studies in breast cancer
Genomic predictors of treatment response in prostate cancer
Synthetic lethality as a basis to select drug combinations
Genomic analysis of childhood tumours; biological and therapeutic implications
Patient-specific peptide vaccines
Proteogenomics in cancer research
Novel models to personalise cancer therapeutics
Editor's Choice for June 2017
Benefits of skin and nipple saving mastectomy
Low dose exemestane usage in breast cancer
Global Status Decade Report on metastatic breast cancer